With a historical specialisation in clinical trials in nutrition and microbiome research, Biofortis aims at becoming the European leader in the field and has strengthened its presence in this area.

In 2023, the Group acquired analyse&realise company based in Berlin, Germany in order to expand its expertise in Europe and create the only partner with 3 internal clinical investigation centres. During this year, Biofortis continues to develop its in-house sequencing platform with the acquisition of DNBSEQ-G99.

Today, their objective remains to support various companies around the world across different segments such as dietary supplements, food but also pharmaceutical companies! Biofortis’ strengths reside in their complex network of scientists and GCP-trained staff along with opinion leaders.

Biofortis’ main areas of research are Gastro-enterology, Woman Health and Pediatrics. Biofortis is also specialised on Cardiovascular, Metabolism, Exercise Physiology, Cognitive Functions, Satiety and Weight Management.
With experts from academia and industry, its Scientific & Strategic Advisory Board is one of the best in analysing scientific data in microbiome sciences.

We are proud to count Biofortis as one of our sponsors for this year’s edition of NutrEvent and can’t wait to welcome them!